{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:08:38Z","timestamp":1759741718854},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Epstein-Barr virus (EBV) has a close association with various types of human lymphomas. Animal models are essential to elucidate the pathogenesis of human EBV-associated lymphomas. The aim of the present study is to evaluate the association between human IgG concentration and EBV-associated lymphoma development in huPBL\/SCID mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Human peripheral blood lymphocytes (hu-PBL) from EBV-seropositive donors were inoculated intraperitoneally into SCID mouse. Immunohistochemical staining was used to examine differentiated antigens of tumor cells. EBV infection of the induced tumors was detected by<jats:italic>in situ<\/jats:italic>hybridization. IgG concentrations in the serums of 12 SCID mice were measured by unidirectional immunodiffusion assay.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>21 out of 29 mice developed tumors in their body. Immunohistochemical staining showed that all induced tumors were LCA (leukocyte common antigen) positive, B-cell markers (CD20, CD79a) positive, and T-cell markers (both CD3 and CD45RO) negative. The tumors can be diagnosed as human B-cell lymphomas by these morphological and immunohistochemical features. In situ hybridization exhibited resultant tumor cells had EBV encoded small RNA-1 (EBER-1). Human-derived IgG could be found in the serum from SCID mice on the 15<jats:sup>th<\/jats:sup>day following hu-PBL transplantation, and IgG levels increased with the tumor development in 6 hu-PBL\/SCID chimeras.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Intraperitoneal transfer of hu-PBLs from EBV+ donors to SCID mice leads to high human IgG levels in mouse serum and B cell lymphomas. Our findings suggest that increasing levels of human-derived IgG in peripheral blood from hu-PBL\/SCID mice could be used to monitor EBV-related human B-cell lymphoma development in experimental animals.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1743-422x-8-213","type":"journal-article","created":{"date-parts":[[2011,5,10]],"date-time":"2011-05-10T18:14:39Z","timestamp":1305051279000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Human-derived IgG level as an indicator for EBV-associated lymphoma model in Hu-PBL\/SCID chimeras"],"prefix":"10.1186","volume":"8","author":[{"given":"Yunlian","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongfang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ailan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimou","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runliang","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,9]]},"reference":[{"issue":"5","key":"1305_CR1","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1634\/theoncologist.2008-0036","volume":"13","author":"A Carbone","year":"2008","unstructured":"Carbone A, Gloghini A, Dotti G: EBV-associated lymphoproliferative disorders: classification and treatment. Oncologist 2008,13(5):577-85. 10.1634\/theoncologist.2008-0036","journal-title":"Oncologist"},{"issue":"1","key":"1305_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1128\/CMR.00044-10","volume":"24","author":"OA Odumade","year":"2011","unstructured":"Odumade OA, Hogquist KA, Balfour HH Jr: Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev 2011,24(1):193-209. 10.1128\/CMR.00044-10","journal-title":"Clin Microbiol Rev"},{"issue":"24","key":"1305_CR3","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.2174\/092986707782023316","volume":"14","author":"E Boccardo","year":"2007","unstructured":"Boccardo E, Villa LL: Viral origins of human cancer. Curr Med Chem 2007,14(24):2526-39. 10.2174\/092986707782023316","journal-title":"Curr Med Chem"},{"issue":"2","key":"1305_CR4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.7883\/yoken.63.132","volume":"6","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Peng J, Tang Y, He J, Peng J, Zhao Q, He R, Xie X, Peng X, Gan R: The prevalence of Epstein-Barr virus infection in different types and sites of lymphomas. Jpn J Infect Dis 2010,6(2):132-35.","journal-title":"Jpn J Infect Dis"},{"issue":"1-2","key":"1305_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jviromet.2006.05.013","volume":"136","author":"J Gao","year":"2006","unstructured":"Gao J, Luo X, Tang K, Li X, Li G: Epstein-Barr virus integrates frequently into chromosome 4q, 2q, 1q and 7q of Burkitt's lymphoma cell line (Raji). J Virol Methods 2006,136(1-2):193-9. 10.1016\/j.jviromet.2006.05.013","journal-title":"J Virol Methods"},{"issue":"2","key":"1305_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.5732\/cjc.010.10377","volume":"30","author":"SM Cao","year":"2011","unstructured":"Cao SM, Simons MJ, Qian CN: The prevalence and prevention of nasopharyngeal carcinoma in China. Chin J Cancer 2011,30(2):114-119.","journal-title":"Chin J Cancer"},{"key":"1305_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-3-540-75647-7_2","volume":"324","author":"T Pearson","year":"2008","unstructured":"Pearson T, Greiner DL, Shultz LD: Humanized SCID mouse models for biomedical research. Curr Top Microbiol Immunol 2008, 324: 25-51. 10.1007\/978-3-540-75647-7_2","journal-title":"Curr Top Microbiol Immunol"},{"issue":"20","key":"1305_CR8","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1182\/blood-2010-02-270678","volume":"116","author":"T Strowig","year":"2010","unstructured":"Strowig T, Chijioke O, Carrega P, Arrey F, Meixlsperger S, R\u00e4mer PC, Ferlazzo G, M\u00fcnz C: Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence. Blood 2010,116(20):4158-67. 10.1182\/blood-2010-02-270678","journal-title":"Blood"},{"issue":"2","key":"1305_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF02698031","volume":"24","author":"NV Frey","year":"2007","unstructured":"Frey NV, Tsai DE: The management of posttransplant lymphoproliferative disorder. Med Oncol 2007,24(2):125-36. 10.1007\/BF02698031","journal-title":"Med Oncol"},{"issue":"9","key":"1305_CR10","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/j.1349-7006.2003.tb01521.x","volume":"94","author":"R Gan","year":"2003","unstructured":"Gan R, Yin Z, Liu T, Wang L, Tang Y, Song Y: Cyclosporine A effectively inhibits graft-versus-host disease during development of Epstein-Barr virus-infected human B cell lymphoma in SCID mouse. Cancer Sci 2003,94(9):796-801. 10.1111\/j.1349-7006.2003.tb01521.x","journal-title":"Cancer Sci"},{"issue":"29","key":"1305_CR11","doi-asserted-by":"publisher","first-page":"13022","DOI":"10.1073\/pnas.1000475107","volume":"107","author":"LD Shultz","year":"2010","unstructured":"Shultz LD, Saito Y, Najima Y, Tanaka S, Ochi T, Tomizawa M, Doi T, Sone A, Suzuki N, Fujiwara H, Yasukawa M, Ishikawa F: Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD\/SCID\/IL2r gamma(null) humanized mice. Proc Natl Acad Sci USA 2010,107(29):13022-7. 10.1073\/pnas.1000475107","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"1305_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.trim.2006.10.006","volume":"17","author":"K Sebelin-Wulf","year":"2007","unstructured":"Sebelin-Wulf K, Nguyen TD, Oertel S, Papp-Vary M, Trappe RU, Schulzki A, Pezzutto A, Riess H, Subklewe M: Quantitative analysis of EBV-specific CD4\/CD8 T cell numbers, absolute CD4\/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD. Transpl Immunol 2007,17(3):203-10. 10.1016\/j.trim.2006.10.006","journal-title":"Transpl Immunol"},{"issue":"2","key":"1305_CR13","first-page":"40","volume":"15","author":"H Khedmat","year":"2010","unstructured":"Khedmat H, Alavian S, Taheri S: Significance of Epstein-Barr virus infection in the outcome of renal transplant patients with lymphoproliferative disorders. Ann Transplant 2010,15(2):40-4.","journal-title":"Ann Transplant"},{"issue":"5","key":"1305_CR14","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1365-2141.2005.05613.x","volume":"130","author":"A Carbone","year":"2005","unstructured":"Carbone A, Gloghini A: AIDS-related lymphomas: from pathogenesis to pathology. Br J Haematol 2005,130(5):662-70. 10.1111\/j.1365-2141.2005.05613.x","journal-title":"Br J Haematol"},{"issue":"8","key":"1305_CR15","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3324\/haematol.12705","volume":"93","author":"D Capello","year":"2008","unstructured":"Capello D, Martini M, Gloghini A, Cerri M, Rasi S, Deambrogi C, Spina M, Tirelli U, Larocca LM, Carbone A, Gaidano G: Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis. Haematologica 2008,93(8):1178-85. 10.3324\/haematol.12705","journal-title":"Haematologica"},{"key":"1305_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-642-56352-2_1","volume":"159","author":"SH Oertel","year":"2002","unstructured":"Oertel SH, Riess H: Immunosurveillance, immunodeficiency and lymphoproliferations. Recent Results Cancer Res 2002, 159: 1-8. 10.1007\/978-3-642-56352-2_1","journal-title":"Recent Results Cancer Res"},{"issue":"6","key":"1305_CR17","first-page":"566","volume":"27","author":"F Ye","year":"2006","unstructured":"Ye F, Chen H, Liang Z, Lu W, Cheng Q, Xie X: Establishment of a cervical cancer model via inoculating SiHa Cells into humanized severe combined immunodeficient mice. Eur J Gynaecol Oncol 2006,27(6):566-72.","journal-title":"Eur J Gynaecol Oncol"},{"key":"1305_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-3-540-75647-7_6","volume":"324","author":"R Ito","year":"2008","unstructured":"Ito R, Shiina M, Saito Y, Tokuda Y, Kametani Y, Habu S: Antigen-specific antibody production of human B cells in NOG mice reconstituted with the human immune system. Curr Top Microbiol Immunol 2008, 324: 95-107. 10.1007\/978-3-540-75647-7_6","journal-title":"Curr Top Microbiol Immunol"},{"issue":"3","key":"1305_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1399-302X.2006.00272.x","volume":"21","author":"MA Salam","year":"2006","unstructured":"Salam MA, Nakao R, Yonezawa H, Watanabe H, Senpuku H: Human T-cell responses to oral streptococci in human PBMC-NOD\/SCID mice. Oral Microbiol Immunol 2006,21(3):169-76. 10.1111\/j.1399-302X.2006.00272.x","journal-title":"Oral Microbiol Immunol"},{"issue":"1","key":"1305_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1128\/CVI.00244-06","volume":"14","author":"J Zhang","year":"2007","unstructured":"Zhang J, Sun R, Tian Z: Human prolactin promotes human secondary immunoglobulin response in human\/SCID mouse chimeras. Clin Vaccine Immunol 2007,14(1):60-4. 10.1128\/CVI.00244-06","journal-title":"Clin Vaccine Immunol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-8-213.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T17:08:30Z","timestamp":1712423310000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-8-213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,9]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1305"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-8-213","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,9]]},"assertion":[{"value":"15 February 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"213"}}